Thierry Passeron, MD, PhD
Invited Speaker:
Oral Gliadin-Protected Superoxide Dismutase in Addition to Phototherapy for Treating Non-segmental Vitiligo: A 24-Week Prospective Randomized Placebo-Controlled Study
Hyun Jeong Ju, MD
Progressive and Extensive Hypomelanosis of Childhood: A Novel Disease Entity Distinguished from Other Hypomelanotic Disorders
Marcella Willemsen, MSc
Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in Peripheral Blood of Segmental and Non-segmental Vitiligo Patients
Nanja van Geel, MD, PhD and Jolien Duponselle, MD
Image Analyses Systems to Calculate the Surface Area of Vitiligo Lesions: A Systematic Review of Measurement Properties
Caroline Le Poole, PhD
Invited Speaker: Modeling Microbial Impact on Autoimmune Depigmentation in Mice
Saurabh Bhatia, MD
Efficacy of NB-UVB in Progressive Versus Non-progressive Non-segmental Vitiligo: A Prospective Comparative Study
2021 VIS Khaled Ezzedine, MD, PhD
Efficacy and Safety of the Oral Janus Kinase 3/Tec Inhibitor Ritlecitinib (PF-06651600) In Adults With Active Non-segmental Vitiligo: Results From a Phase 2b, Randomized, Dose-Ranging Study With an Extension Period
Beth Schneider, PhD
Research – MyVitiligoTeam (Social Network)
Poster Q&A Session #1
Shiwangi Rana, MD;
Alpana Mohta, MD;
Ju Hee Han, MD;
Fabiana Castro Porto Silva Lopes, MD;
Mauro Picardo, MD
Invited Speaker – Vitiligo: A Diverse Perspective